Page 106 - ITPS-8-1

INNOSC Theranostics and
Pharmacological Sciences BDNF-AS biomarker in multiple sclerosis

doi: 10.3390/jpm13040652 hydrocephalus and healthy controls. J Psychiatr Res.
2007;41(5):387-394.
37. Ikeda Y, Yahata N, Ito I, et al. Low serum levels of brain-
derived neurotrophic factor and epidermal growth factor doi: 10.1016/j.jpsychires.2006.01.014
in patients with chronic schizophrenia. Schizophr Res. 42. Lee JG, Shin BS, You YS, et al. Decreased serum brain-
2008;101(1-3):58-66.
derived neurotrophic factor levels in elderly Korean with
doi: 10.1016/j.schres.2008.01.017 dementia. Psychiatry Investig. 2009;6(4):299.
38. Ahmad R, Azman KF, Yahaya R, et al. Brain-derived doi: 10.4306/pi.2009.6.4.299
neurotrophic factor (BDNF) in schizophrenia research: 43. Zuccato C, Marullo M, Vitali B, et al. Brain-derived
A quantitative review and future directions. AIMS Neurosci.
2023;10(1):5-3. neurotrophic factor in patients with Huntington’s disease.
PLoS One. 2011;6(8):e22966.
doi: 10.3934/Neuroscience.2023002
doi: 10.1371/journal.pone.0022966
39. Molendijk ML, Spinhoven P, Polak M, Bus BAA,
Penninx B, Elzinga BM. Serum BDNF concentrations as 44. Ciammola A, Sassone J, Cannella M, et al. Low brain‐derived
peripheral manifestations of depression: Evidence from a neurotrophic factor (BDNF) levels in serum of Huntington’s
systematic review and meta-analyses on 179 associations disease patients. Am J Med Genet Part B: Neuropsychiatr
(N= 9484). Mol Psychiatry. 2014;19(7):791-800. Genet. 2007;144(4):574-577.
doi: 10.1002/ajmg.b.30501
doi: 10.1038/mp.2013.105
45. Armeanu R, Mokkonen M, Crespi B. Meta-analysis of BDNF
40. Zarza-Rebollo JA, López-Isac E, Rivera M, Gómez-
Hernández L, Pérez-Gutiérrez AM, Molina E. The levels in autism. Cell Mol Neurobiol. 2017;37(5):949-954.
relationship between BDNF and physical activity on doi: 10.1007/s10571-016-0415-7
depression. Prog Neuropsychopharmacol Biol Psychiatry. 46. Modarresi F, Faghihi MA, Lopez-Toledano MA, et al.
2024;134:111033.
Inhibition of natural antisense transcripts in vivo results in
doi: 10.1016/j.pnpbp.2024.111033 gene-specific transcriptional upregulation. Nat Biotechnol.
2012;30(5):453-459.
41. Laske C, Stransky E, Leyhe T, et al. BDNF serum and CSF
concentrations in Alzheimer’s disease, normal pressure doi: 10.1038/nbt.2158

Volume 8 Issue 1 (2025) 100 doi: 10.36922/itps.4407